Legend Biotech Corp
LEGNNasdaqHealthcare · Pharmaceutical Preparations · E9 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Clinical trials
ClinicalTrials.gov · ongoing · next readout first- Phase 1Active Not Recruitingreadout ~2027-12DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer
- Phase 1Active Not Recruitingreadout ~2027-12Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma
Interventional studies led by this company. “Readout” is the trial's primary-completion date — an estimate the sponsor reports, not a guarantee.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Fmr LlcPassive (13G)Feb 5, 2026
- Price T Rowe Associates Inc /Md/Passive (13G)Feb 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 14.4M | 4.7 | -15.1% |
| Apr 30, 2026 | 17.0M | 6.2 | -11.6% |
| Apr 15, 2026 | 19.2M | 10.9 | +2.7% |
| Mar 31, 2026 | 18.7M | 15.6 | +4.0% |
| Mar 13, 2026 | 18.0M | 11.4 | -10.3% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Recent SEC filings
All filings ↗- 6-KFORM 6-KJun 1, 2026
- 6-KFORM 6-KMay 21, 2026
- 6-KMay 12, 2026
- 6-KFORM 6-KApr 14, 2026
- 4Mar 27, 2026
- 144Mar 26, 2026
- 144Mar 26, 2026
- 3Mar 18, 2026
- 3Mar 18, 2026
- 3Mar 18, 2026
- 3Mar 18, 2026
- 3Mar 18, 2026
- 3Mar 18, 2026
- 3Mar 18, 2026
- 3Mar 18, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.